EXHIBIT 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Corbus Pharmaceuticals Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Newly Registered Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Security Type

Security

Class

Title

Fee

Calculation

Rule

Amount

Registered

Proposed

Maximum

Offering

Price Per

Share

Maximum

Aggregate

Offering

Price

Fee

Rate

Amount of

Registration

Fee

Equity

Common Stock, $0.0001 par value per share

457(o)

(1)

(1)

(1)

Equity

Preferred Stock, $0.0001 par value per share

457(o)

(1)

(1)

(1)

Debt

Debt Securities

457(o)

(1)

(1)

(1)

Other

Warrants

457(o)

(1)

(1)

(1)

Other

Units

457(o)

(1)

(1)

(1)

Other

Subscription Rights

457(o)

(1)

(1)

(1)

Unallocated (Universal) Shelf

---

457(o)

(1)

(1)

$15,752,564

0.00014760

$2,325.08

Total Offering Amounts

$15,752,564

$2,325.08

Total Fees Paid Previously

Total Fee Offsets

Net Fee Due

$2,325.08

(1)

The Registrant previously registered the offer and sale of certain securities having a proposed maximum aggregate offering price of $100,000,000 pursuant to a Registration Statement on Form S-3 (File No. 333-272314) (the “Prior Registration Statement”), which was initially filed on June 1, 2023 and declared effective by the Securities and Exchange Commission on June 13, 2023. As of the date hereof, a balance of $78,762,823 of such securities remains unsold under the Prior Registration Statement. In accordance with Rule 462(b) under the Securities Act of 1933, as amended, and General Instruction IV(A) of Form S-3, the registrant is hereby registering the offer and sale of an additional $15,752,564 of its Securities. The additional amount of Securities that is being registered for offer and sale represents no more than 20% of the maximum aggregate offering price of the remaining securities available to be sold under the Prior Registration Statement.